Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Nirrin Technologies, Inc. maintains a patent portfolio in the Chemistry & Materials technology area with 3 pending office actions. This workload is distributed across 3 distinct examiners and 2 distinct art units, indicating a more diversified prosecution footprint than single-action portfolios. GZYBOWSKI, MICHAEL STANLEY is identified as the busiest examiner, currently handling 1 busiest examiner pending action. The presence of 3 distinct examiners suggests that the company is engaging with multiple perspectives at the USPTO.
With 2 distinct art units involved, the portfolio likely covers a range of technical sub-specialties within the chemistry field. Practitioners should monitor the outcomes across these different units to identify any trends in examiner behavior or art unit specific hurdles. The distribution of 3 pending office actions across 3 distinct examiners provides a broader base of experience than a more concentrated portfolio. This diversity allows for a more nuanced understanding of how different examiners within the 2 distinct art units interpret the company's core technologies. Managing 1 busiest examiner pending action under GZYBOWSKI, MICHAEL STANLEY requires a focused strategy within this larger framework.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GZYBOWSKI, MICHAEL STANLEY | 1 | 68.3% | +52.0% |
| LOPEZLIRA, ASHLEY NICOLE | 1 | 71.2% | +42.0% |
| HASSAN, LIBAN M | 1 | 50.7% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17696635 | Rocking Bioreactor with Integrated Monitoring Probe System | LOPEZLIRA, ASHLEY NICOLE | — |
| 17337055 | Disposable Cell for In Situ Monitoring Probe | HASSAN, LIBAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17893279 | Laser speckle imaging for live cell quantification | GZYBOWSKI, MICHAEL STANLEY | — |
| 17696635 | Rocking Bioreactor with Integrated Monitoring Probe System | LOPEZLIRA, ASHLEY NICOLE | — |
| 17337055 | Disposable Cell for In Situ Monitoring Probe | HASSAN, LIBAN M | — |
| Art Unit | Apps |
|---|---|
| 1799 | 2 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17893279 | Laser speckle imaging for live cell quantification | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | — | Pending | Aug 23, 2022 |
| 17696635 | Rocking Bioreactor with Integrated Monitoring Probe System | LOPEZLIRA, ASHLEY NICOLE | 1799 | §102§103§112 | Non-Final OA | — | Pending | Mar 16, 2022 |
| 17337055 | Disposable Cell for In Situ Monitoring Probe | HASSAN, LIBAN M | 1799 | §102§103 | Non-Final OA | — | Pending | Jun 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial